01
The company has mastered a series of proprietary peptide scale production core technologies that reduce production costs, improve production efficiency, and enhance product quality, as well as leading technologies related to the development of new peptide drugs; Simultaneously established a formulation technology platform for multiple dosage forms; Having a complete and efficient industrialization system for peptide drugs, with profound technical accumulation and rich research and development achievements in the field of peptide drug development.









